INDICATORS ON CLINICAL TRIAL RECRUITMENT FOR ABBV-744 STUDY YOU SHOULD KNOW

In Phase A, members will obtain diverse doses and schedules of oral ABBV-744 pill to establish Risk-free dosing regimen. Extra contributors are going to be enrolled for the recognized monotherapy dosign regimen. In Phase B, individuals will receive oral ruxolitinib and ABBV-744 are going to be supplied as "incorporate-on" therapy. In Segment C, mem